Pilar Martı́nez - Concepedia

Author

Pilar Martı́nez

Hospital Universitari i Politècnic La Fe ORCID

Also Known As

Blanca Boluda, Ferran Vall-Llovera, Karen Macdougald, Olga Merino, P J Martínez, P Martinez, P Martínez, P. Cerezuela Martinez, P. Martinez, P. Martínez

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari i Politècnic La Fe Hospital General Universitario de Alicante Doctor Balmis Universidad de Salamanca Research Institute Hospital 12 de Octubre Centro de Investigación Biomédica en Red de Cáncer

About

Pilar Martı́nez is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	288
2	Biostatistics	2	2	186
3	Engineering	1	1	174
4	Health Sciences	1	1	12
5	Epidemiology	1	1	174

Pilar Martı́nez

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Mutational Status of the <i>TP53</i> Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial David González, Pilar Martı́nez, Rachel Wade, Journal of Clinical Oncology	2011	263
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry. María Eugenia Sarasquete, Ramón García‐Sánz, David González, PubMed	2005	184
Challenges of DNA profiling in mass disaster investigations. Antonio Alonso, Pablo Martı́n, Cristina Albarrán, PubMed EngineeringGeneticsDna AnalysisInformation ForensicsGenomics	2005	174
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile Lourdes Martín‐Martín, Antonio López, María‐Belén Vídriales, Oncotarget	2015	120
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts Linus Angenendt, Christoph Röllig, Pau Montesinos, Journal of Clinical Oncology	2019	113
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia Josep‐María Ribera, Olga García‐Calduch, Jordi Ribera, Blood Advances Tyrosine Kinase InhibitorHematological MalignancyTransplantationOncologyPh+ All	2022	55
Kikuchi's Disease With Multisystemic Involvement and Adverse Reaction to Drugs Maria L. Murga Sierra, Eva Vegas, Javier E. Blanco-González, PEDIATRICS Liver FailureAutoimmune DiseaseVasculitisImmunodeficienciesPathogenesis	1999	47
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group Tomás Palanques-Pastor, Juan Eduardo Megías‐Vericat, Pilar Martı́nez, Leukemia & lymphoma/Leukemia and lymphoma	2021	33
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial Catia Simoes, Bruno Paiva, David Martínez‐Cuadrón, Blood Advances	2021	25
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry Margalida Calafat, Míriam Mañosa, Elena Ricart, Journal of Crohn s and Colitis	2021	14

Page 1